| Dataset | w1a_vs_wt_vs_wt.w1a_vs_wt.cls #ago1w1a_versus_ago1gfp.w1a_vs_wt.cls #ago1w1a_versus_ago1gfp_repos |
| Phenotype | w1a_vs_wt.cls#ago1w1a_versus_ago1gfp_repos |
| Upregulated in class | ago1w1a |
| GeneSet | HALLMARK_APOPTOSIS |
| Enrichment Score (ES) | 0.444422 |
| Normalized Enrichment Score (NES) | 1.7379313 |
| Nominal p-value | 0.0 |
| FDR q-value | 0.0029051679 |
| FWER p-Value | 0.016 |

| PROBE | DESCRIPTION (from dataset) | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|---|---|---|
| 1 | IGFBP6 | NA | IGFBP6 Entrez,  Source | insulin-like growth factor binding protein 6 | 9 | 4.746 | 0.0366 | Yes |
| 2 | IL6 | NA | IL6 Entrez,  Source | interleukin 6 (interferon, beta 2) | 17 | 4.596 | 0.0722 | Yes |
| 3 | ISG20 | NA | ISG20 Entrez,  Source | interferon stimulated exonuclease gene 20kDa | 19 | 4.561 | 0.1078 | Yes |
| 4 | PMAIP1 | NA | PMAIP1 Entrez,  Source | phorbol-12-myristate-13-acetate-induced protein 1 | 110 | 3.103 | 0.1271 | Yes |
| 5 | IRF1 | NA | IRF1 Entrez,  Source | interferon regulatory factor 1 | 112 | 3.067 | 0.1510 | Yes |
| 6 | BIRC3 | NA | BIRC3 Entrez,  Source | baculoviral IAP repeat-containing 3 | 182 | 2.484 | 0.1666 | Yes |
| 7 | TNFRSF12A | NA | TNFRSF12A Entrez,  Source | tumor necrosis factor receptor superfamily, member 12A | 203 | 2.387 | 0.1842 | Yes |
| 8 | SOD2 | NA | SOD2 Entrez,  Source | superoxide dismutase 2, mitochondrial | 263 | 2.124 | 0.1975 | Yes |
| 9 | TAP1 | NA | TAP1 Entrez,  Source | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 315 | 1.921 | 0.2097 | Yes |
| 10 | KRT18 | NA | KRT18 Entrez,  Source | keratin 18 | 372 | 1.771 | 0.2205 | Yes |
| 11 | BIK | NA | BIK Entrez,  Source | BCL2-interacting killer (apoptosis-inducing) | 404 | 1.710 | 0.2321 | Yes |
| 12 | GNA15 | NA | GNA15 Entrez,  Source | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 500 | 1.540 | 0.2389 | Yes |
| 13 | BCL2L1 | NA | BCL2L1 Entrez,  Source | BCL2-like 1 | 512 | 1.526 | 0.2502 | Yes |
| 14 | CD44 | NA | CD44 Entrez,  Source | CD44 molecule (Indian blood group) | 515 | 1.523 | 0.2620 | Yes |
| 15 | EREG | NA | EREG Entrez,  Source | epiregulin | 553 | 1.479 | 0.2715 | Yes |
| 16 | MCL1 | NA | MCL1 Entrez,  Source | myeloid cell leukemia sequence 1 (BCL2-related) | 561 | 1.471 | 0.2827 | Yes |
| 17 | TGFB2 | NA | TGFB2 Entrez,  Source | transforming growth factor, beta 2 | 589 | 1.429 | 0.2923 | Yes |
| 18 | NEDD9 | NA | NEDD9 Entrez,  Source | neural precursor cell expressed, developmentally down-regulated 9 | 643 | 1.376 | 0.3002 | Yes |
| 19 | IL1A | NA | IL1A Entrez,  Source | interleukin 1, alpha | 647 | 1.371 | 0.3107 | Yes |
| 20 | GPX3 | NA | GPX3 Entrez,  Source | glutathione peroxidase 3 (plasma) | 688 | 1.332 | 0.3189 | Yes |
| 21 | JUN | NA | JUN Entrez,  Source | jun oncogene | 718 | 1.312 | 0.3276 | Yes |
| 22 | IL1B | NA | IL1B Entrez,  Source | interleukin 1, beta | 779 | 1.262 | 0.3341 | Yes |
| 23 | SQSTM1 | NA | SQSTM1 Entrez,  Source | sequestosome 1 | 787 | 1.257 | 0.3435 | Yes |
| 24 | GADD45A | NA | GADD45A Entrez,  Source | growth arrest and DNA-damage-inducible, alpha | 828 | 1.225 | 0.3509 | Yes |
| 25 | PEA15 | NA | PEA15 Entrez,  Source | phosphoprotein enriched in astrocytes 15 | 859 | 1.203 | 0.3587 | Yes |
| 26 | CASP1 | NA | CASP1 Entrez,  Source | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 897 | 1.178 | 0.3658 | Yes |
| 27 | CASP4 | NA | CASP4 Entrez,  Source | caspase 4, apoptosis-related cysteine peptidase | 946 | 1.147 | 0.3721 | Yes |
| 28 | SLC20A1 | NA | SLC20A1 Entrez,  Source | solute carrier family 20 (phosphate transporter), member 1 | 962 | 1.138 | 0.3802 | Yes |
| 29 | BCL10 | NA | BCL10 Entrez,  Source | B-cell CLL/lymphoma 10 | 1035 | 1.099 | 0.3848 | Yes |
| 30 | RELA | NA | RELA Entrez,  Source | v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 (avian) | 1150 | 1.047 | 0.3866 | Yes |
| 31 | TNF | NA | TNF Entrez,  Source | tumor necrosis factor (TNF superfamily, member 2) | 1210 | 1.015 | 0.3913 | Yes |
| 32 | IFITM3 | NA | IFITM3 Entrez,  Source | interferon induced transmembrane protein 3 (1-8U) | 1361 | 0.959 | 0.3905 | Yes |
| 33 | CASP2 | NA | CASP2 Entrez,  Source | caspase 2, apoptosis-related cysteine peptidase (neural precursor cell expressed, developmentally down-regulated 2) | 1465 | 0.921 | 0.3920 | Yes |
| 34 | CREBBP | NA | CREBBP Entrez,  Source | CREB binding protein (Rubinstein-Taybi syndrome) | 1528 | 0.903 | 0.3956 | Yes |
| 35 | CCNA1 | NA | CCNA1 Entrez,  Source | cyclin A1 | 1571 | 0.891 | 0.4002 | Yes |
| 36 | FAS | NA | FAS Entrez,  Source | Fas (TNF receptor superfamily, member 6) | 1600 | 0.881 | 0.4056 | Yes |
| 37 | LMNA | NA | LMNA Entrez,  Source | lamin A/C | 1617 | 0.876 | 0.4115 | Yes |
| 38 | GPX1 | NA | GPX1 Entrez,  Source | glutathione peroxidase 1 | 1814 | 0.826 | 0.4071 | Yes |
| 39 | IL18 | NA | IL18 Entrez,  Source | interleukin 18 (interferon-gamma-inducing factor) | 1911 | 0.805 | 0.4081 | Yes |
| 40 | H1F0 | NA | H1F0 Entrez,  Source | H1 histone family, member 0 | 1944 | 0.799 | 0.4126 | Yes |
| 41 | GCH1 | NA | GCH1 Entrez,  Source | GTP cyclohydrolase 1 (dopa-responsive dystonia) | 1976 | 0.792 | 0.4170 | Yes |
| 42 | TGFBR3 | NA | TGFBR3 Entrez,  Source | transforming growth factor, beta receptor III (betaglycan, 300kDa) | 2021 | 0.784 | 0.4207 | Yes |
| 43 | CASP7 | NA | CASP7 Entrez,  Source | caspase 7, apoptosis-related cysteine peptidase | 2131 | 0.758 | 0.4206 | Yes |
| 44 | CYLD | NA | CYLD Entrez,  Source | cylindromatosis (turban tumor syndrome) | 2158 | 0.752 | 0.4250 | Yes |
| 45 | DNAJA1 | NA | DNAJA1 Entrez,  Source | DnaJ (Hsp40) homolog, subfamily A, member 1 | 2215 | 0.741 | 0.4277 | Yes |
| 46 | DDIT3 | NA | DDIT3 Entrez,  Source | DNA-damage-inducible transcript 3 | 2275 | 0.729 | 0.4302 | Yes |
| 47 | RNASEL | NA | RNASEL Entrez,  Source | ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) | 2282 | 0.728 | 0.4355 | Yes |
| 48 | RARA | NA | RARA Entrez,  Source | retinoic acid receptor, alpha | 2290 | 0.726 | 0.4408 | Yes |
| 49 | ANXA1 | NA | ANXA1 Entrez,  Source | annexin A1 | 2327 | 0.718 | 0.4444 | Yes |
| 50 | TNFSF10 | NA | TNFSF10 Entrez,  Source | tumor necrosis factor (ligand) superfamily, member 10 | 2436 | 0.696 | 0.4439 | No |
| 51 | HSPB1 | NA | HSPB1 Entrez,  Source | heat shock 27kDa protein 1 | 2793 | 0.631 | 0.4290 | No |
| 52 | RETSAT | NA | RETSAT Entrez,  Source | retinol saturase (all-trans-retinol 13,14-reductase) | 2802 | 0.630 | 0.4335 | No |
| 53 | BCL2L11 | NA | BCL2L11 Entrez,  Source | BCL2-like 11 (apoptosis facilitator) | 2880 | 0.617 | 0.4341 | No |
| 54 | CASP3 | NA | CASP3 Entrez,  Source | caspase 3, apoptosis-related cysteine peptidase | 2903 | 0.613 | 0.4377 | No |
| 55 | CD14 | NA | CD14 Entrez,  Source | CD14 molecule | 2918 | 0.610 | 0.4417 | No |
| 56 | IFNGR1 | NA | IFNGR1 Entrez,  Source | interferon gamma receptor 1 | 3151 | 0.575 | 0.4333 | No |
| 57 | WEE1 | NA | WEE1 Entrez,  Source | WEE1 homolog (S. pombe) | 3241 | 0.561 | 0.4327 | No |
| 58 | DNAJC3 | NA | DNAJC3 Entrez,  Source | DnaJ (Hsp40) homolog, subfamily C, member 3 | 3652 | 0.504 | 0.4139 | No |
| 59 | ERBB2 | NA | ERBB2 Entrez,  Source | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 3754 | 0.491 | 0.4121 | No |
| 60 | TIMP1 | NA | TIMP1 Entrez,  Source | TIMP metallopeptidase inhibitor 1 | 3797 | 0.486 | 0.4136 | No |
| 61 | TIMP3 | NA | TIMP3 Entrez,  Source | TIMP metallopeptidase inhibitor 3 (Sorsby fundus dystrophy, pseudoinflammatory) | 3807 | 0.484 | 0.4169 | No |
| 62 | TSPO | NA | TSPO Entrez,  Source | translocator protein (18kDa) | 4148 | 0.441 | 0.4015 | No |
| 63 | PSEN1 | NA | PSEN1 Entrez,  Source | presenilin 1 (Alzheimer disease 3) | 4203 | 0.434 | 0.4018 | No |
| 64 | PLAT | NA | PLAT Entrez,  Source | plasminogen activator, tissue | 4378 | 0.414 | 0.3954 | No |
| 65 | BCAP31 | NA | BCAP31 Entrez,  Source | B-cell receptor-associated protein 31 | 4435 | 0.407 | 0.3955 | No |
| 66 | CCND1 | NA | CCND1 Entrez,  Source | cyclin D1 | 4440 | 0.407 | 0.3985 | No |
| 67 | HMOX1 | NA | HMOX1 Entrez,  Source | heme oxygenase (decycling) 1 | 5118 | 0.340 | 0.3635 | No |
| 68 | LEF1 | NA | LEF1 Entrez,  Source | lymphoid enhancer-binding factor 1 | 5206 | 0.331 | 0.3613 | No |
| 69 | PAK1 | NA | PAK1 Entrez,  Source | p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast) | 5493 | 0.303 | 0.3478 | No |
| 70 | APP | NA | APP Entrez,  Source | amyloid beta (A4) precursor protein (peptidase nexin-II, Alzheimer disease) | 5577 | 0.297 | 0.3455 | No |
| 71 | CASP8 | NA | CASP8 Entrez,  Source | caspase 8, apoptosis-related cysteine peptidase | 5677 | 0.288 | 0.3423 | No |
| 72 | PPP2R5B | NA | PPP2R5B Entrez,  Source | protein phosphatase 2, regulatory subunit B (B56), beta isoform | 5684 | 0.288 | 0.3442 | No |
| 73 | BAX | NA | BAX Entrez,  Source | BCL2-associated X protein | 5783 | 0.280 | 0.3409 | No |
| 74 | DIABLO | NA | DIABLO Entrez,  Source | diablo homolog (Drosophila) | 5896 | 0.270 | 0.3368 | No |
| 75 | DNM1L | NA | DNM1L Entrez,  Source | dynamin 1-like | 6205 | 0.245 | 0.3216 | No |
| 76 | DAP | NA | DAP Entrez,  Source | death-associated protein | 6228 | 0.243 | 0.3223 | No |
| 77 | MGMT | NA | MGMT Entrez,  Source | O-6-methylguanine-DNA methyltransferase | 6410 | 0.228 | 0.3140 | No |
| 78 | CASP6 | NA | CASP6 Entrez,  Source | caspase 6, apoptosis-related cysteine peptidase | 6428 | 0.227 | 0.3149 | No |
| 79 | MADD | NA | MADD Entrez,  Source | MAP-kinase activating death domain | 6456 | 0.225 | 0.3151 | No |
| 80 | BRCA1 | NA | BRCA1 Entrez,  Source | breast cancer 1, early onset | 6475 | 0.223 | 0.3159 | No |
| 81 | CD38 | NA | CD38 Entrez,  Source | CD38 molecule | 6476 | 0.223 | 0.3176 | No |
| 82 | PSEN2 | NA | PSEN2 Entrez,  Source | presenilin 2 (Alzheimer disease 4) | 6478 | 0.223 | 0.3193 | No |
| 83 | MMP2 | NA | MMP2 Entrez,  Source | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 6602 | 0.212 | 0.3141 | No |
| 84 | DFFA | NA | DFFA Entrez,  Source | DNA fragmentation factor, 45kDa, alpha polypeptide | 6781 | 0.197 | 0.3058 | No |
| 85 | CDC25B | NA | CDC25B Entrez,  Source | cell division cycle 25B | 6915 | 0.186 | 0.2999 | No |
| 86 | SAT1 | NA | SAT1 Entrez,  Source | spermidine/spermine N1-acetyltransferase 1 | 7099 | 0.174 | 0.2911 | No |
| 87 | PPP3R1 | NA | PPP3R1 Entrez,  Source | protein phosphatase 3 (formerly 2B), regulatory subunit B, 19kDa, alpha isoform (calcineurin B, type I) | 7244 | 0.164 | 0.2844 | No |
| 88 | AVPR1A | NA | AVPR1A Entrez,  Source | arginine vasopressin receptor 1A | 7423 | 0.150 | 0.2757 | No |
| 89 | AIFM3 | NA | 7428 | 0.149 | 0.2766 | No | ||
| 90 | CDKN1A | NA | CDKN1A Entrez,  Source | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 7523 | 0.143 | 0.2725 | No |
| 91 | IFNB1 | NA | IFNB1 Entrez,  Source | interferon, beta 1, fibroblast | 7718 | 0.129 | 0.2627 | No |
| 92 | LGALS3 | NA | LGALS3 Entrez,  Source | lectin, galactoside-binding, soluble, 3 (galectin 3) | 7958 | 0.111 | 0.2503 | No |
| 93 | RHOT2 | NA | RHOT2 Entrez,  Source | ras homolog gene family, member T2 | 8047 | 0.104 | 0.2463 | No |
| 94 | BCL2L10 | NA | BCL2L10 Entrez,  Source | BCL2-like 10 (apoptosis facilitator) | 8089 | 0.100 | 0.2448 | No |
| 95 | HGF | NA | HGF Entrez,  Source | hepatocyte growth factor (hepapoietin A; scatter factor) | 8193 | 0.093 | 0.2398 | No |
| 96 | ROCK1 | NA | ROCK1 Entrez,  Source | Rho-associated, coiled-coil containing protein kinase 1 | 8743 | 0.055 | 0.2097 | No |
| 97 | ENO2 | NA | ENO2 Entrez,  Source | enolase 2 (gamma, neuronal) | 8999 | 0.035 | 0.1958 | No |
| 98 | SPTAN1 | NA | SPTAN1 Entrez,  Source | spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) | 9142 | 0.024 | 0.1881 | No |
| 99 | EMP1 | NA | EMP1 Entrez,  Source | epithelial membrane protein 1 | 9256 | 0.016 | 0.1820 | No |
| 100 | GUCY2D | NA | GUCY2D Entrez,  Source | guanylate cyclase 2D, membrane (retina-specific) | 9347 | 0.011 | 0.1771 | No |
| 101 | DAP3 | NA | DAP3 Entrez,  Source | death associated protein 3 | 9363 | 0.010 | 0.1763 | No |
| 102 | BCL2L2 | NA | BCL2L2 Entrez,  Source | BCL2-like 2 | 9756 | -0.003 | 0.1546 | No |
| 103 | CCND2 | NA | CCND2 Entrez,  Source | cyclin D2 | 10056 | -0.023 | 0.1382 | No |
| 104 | FDXR | NA | FDXR Entrez,  Source | ferredoxin reductase | 10185 | -0.030 | 0.1313 | No |
| 105 | XIAP | NA | 10443 | -0.045 | 0.1174 | No | ||
| 106 | PRF1 | NA | PRF1 Entrez,  Source | perforin 1 (pore forming protein) | 10618 | -0.055 | 0.1082 | No |
| 107 | GSTM1 | NA | GSTM1 Entrez,  Source | glutathione S-transferase M1 | 10630 | -0.056 | 0.1080 | No |
| 108 | GSR | NA | GSR Entrez,  Source | glutathione reductase | 10665 | -0.059 | 0.1066 | No |
| 109 | CFLAR | NA | CFLAR Entrez,  Source | CASP8 and FADD-like apoptosis regulator | 10825 | -0.067 | 0.0982 | No |
| 110 | ADD1 | NA | ADD1 Entrez,  Source | adducin 1 (alpha) | 11353 | -0.102 | 0.0698 | No |
| 111 | BID | NA | BID Entrez,  Source | BH3 interacting domain death agonist | 11556 | -0.119 | 0.0595 | No |
| 112 | PTK2 | NA | PTK2 Entrez,  Source | PTK2 protein tyrosine kinase 2 | 11849 | -0.144 | 0.0444 | No |
| 113 | PLCB2 | NA | PLCB2 Entrez,  Source | phospholipase C, beta 2 | 11908 | -0.148 | 0.0423 | No |
| 114 | GADD45B | NA | GADD45B Entrez,  Source | growth arrest and DNA-damage-inducible, beta | 11970 | -0.153 | 0.0402 | No |
| 115 | SMAD7 | NA | SMAD7 Entrez,  Source | SMAD, mothers against DPP homolog 7 (Drosophila) | 12163 | -0.170 | 0.0308 | No |
| 116 | ETF1 | NA | ETF1 Entrez,  Source | eukaryotic translation termination factor 1 | 12340 | -0.186 | 0.0225 | No |
| 117 | EBP | NA | EBP Entrez,  Source | emopamil binding protein (sterol isomerase) | 12468 | -0.198 | 0.0170 | No |
| 118 | BGN | NA | BGN Entrez,  Source | biglycan | 12475 | -0.199 | 0.0182 | No |
| 119 | RHOB | NA | RHOB Entrez,  Source | ras homolog gene family, member B | 12525 | -0.204 | 0.0171 | No |
| 120 | CTNNB1 | NA | CTNNB1 Entrez,  Source | catenin (cadherin-associated protein), beta 1, 88kDa | 12660 | -0.216 | 0.0114 | No |
| 121 | IER3 | NA | IER3 Entrez,  Source | immediate early response 3 | 13360 | -0.277 | -0.0253 | No |
| 122 | IGF2R | NA | IGF2R Entrez,  Source | insulin-like growth factor 2 receptor | 13479 | -0.290 | -0.0296 | No |
| 123 | FASLG | NA | FASLG Entrez,  Source | Fas ligand (TNF superfamily, member 6) | 13862 | -0.326 | -0.0482 | No |
| 124 | SOD1 | NA | SOD1 Entrez,  Source | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | 13992 | -0.344 | -0.0527 | No |
| 125 | CAV1 | NA | CAV1 Entrez,  Source | caveolin 1, caveolae protein, 22kDa | 13996 | -0.345 | -0.0502 | No |
| 126 | VDAC2 | NA | VDAC2 Entrez,  Source | voltage-dependent anion channel 2 | 14442 | -0.398 | -0.0718 | No |
| 127 | F2R | NA | F2R Entrez,  Source | coagulation factor II (thrombin) receptor | 14494 | -0.404 | -0.0714 | No |
| 128 | CD69 | NA | CD69 Entrez,  Source | CD69 molecule | 14577 | -0.416 | -0.0727 | No |
| 129 | CDK2 | NA | CDK2 Entrez,  Source | cyclin-dependent kinase 2 | 14672 | -0.427 | -0.0746 | No |
| 130 | BTG3 | NA | BTG3 Entrez,  Source | BTG family, member 3 | 14860 | -0.457 | -0.0814 | No |
| 131 | F2 | NA | F2 Entrez,  Source | coagulation factor II (thrombin) | 14879 | -0.459 | -0.0788 | No |
| 132 | TXNIP | NA | TXNIP Entrez,  Source | thioredoxin interacting protein | 14955 | -0.469 | -0.0793 | No |
| 133 | GSN | NA | GSN Entrez,  Source | gelsolin (amyloidosis, Finnish type) | 15393 | -0.531 | -0.0994 | No |
| 134 | FEZ1 | NA | FEZ1 Entrez,  Source | fasciculation and elongation protein zeta 1 (zygin I) | 15442 | -0.540 | -0.0979 | No |
| 135 | NEFH | NA | NEFH Entrez,  Source | neurofilament, heavy polypeptide 200kDa | 15853 | -0.622 | -0.1158 | No |
| 136 | DPYD | NA | DPYD Entrez,  Source | dihydropyrimidine dehydrogenase | 15908 | -0.634 | -0.1138 | No |
| 137 | PPT1 | NA | PPT1 Entrez,  Source | palmitoyl-protein thioesterase 1 (ceroid-lipofuscinosis, neuronal 1, infantile) | 16196 | -0.705 | -0.1242 | No |
| 138 | TOP2A | NA | TOP2A Entrez,  Source | topoisomerase (DNA) II alpha 170kDa | 16265 | -0.724 | -0.1223 | No |
| 139 | GPX4 | NA | GPX4 Entrez,  Source | glutathione peroxidase 4 (phospholipid hydroperoxidase) | 16319 | -0.740 | -0.1195 | No |
| 140 | BMP2 | NA | BMP2 Entrez,  Source | bone morphogenetic protein 2 | 16401 | -0.765 | -0.1180 | No |
| 141 | SATB1 | NA | SATB1 Entrez,  Source | special AT-rich sequence binding protein 1 (binds to nuclear matrix/scaffold-associating DNA's) | 16579 | -0.821 | -0.1214 | No |
| 142 | TIMP2 | NA | TIMP2 Entrez,  Source | TIMP metallopeptidase inhibitor 2 | 16590 | -0.824 | -0.1155 | No |
| 143 | CDKN1B | NA | CDKN1B Entrez,  Source | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 16862 | -0.909 | -0.1234 | No |
| 144 | ERBB3 | NA | ERBB3 Entrez,  Source | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 16960 | -0.952 | -0.1214 | No |
| 145 | HMGB2 | NA | HMGB2 Entrez,  Source | high-mobility group box 2 | 16990 | -0.964 | -0.1154 | No |
| 146 | CD2 | NA | CD2 Entrez,  Source | CD2 molecule | 17032 | -0.986 | -0.1100 | No |
| 147 | CTH | NA | CTH Entrez,  Source | cystathionase (cystathionine gamma-lyase) | 17134 | -1.027 | -0.1076 | No |
| 148 | EGR3 | NA | EGR3 Entrez,  Source | early growth response 3 | 17235 | -1.079 | -0.1047 | No |
| 149 | CASP9 | NA | CASP9 Entrez,  Source | caspase 9, apoptosis-related cysteine peptidase | 17671 | -1.437 | -0.1176 | No |
| 150 | PDCD4 | NA | PDCD4 Entrez,  Source | programmed cell death 4 (neoplastic transformation inhibitor) | 17740 | -1.515 | -0.1095 | No |
| 151 | ANKH | NA | ANKH Entrez,  Source | ankylosis, progressive homolog (mouse) | 17759 | -1.546 | -0.0984 | No |
| 152 | BNIP3L | NA | BNIP3L Entrez,  Source | BCL2/adenovirus E1B 19kDa interacting protein 3-like | 17802 | -1.619 | -0.0881 | No |
| 153 | PDGFRB | NA | PDGFRB Entrez,  Source | platelet-derived growth factor receptor, beta polypeptide | 17904 | -1.866 | -0.0791 | No |
| 154 | LUM | NA | LUM Entrez,  Source | lumican | 17955 | -2.047 | -0.0659 | No |
| 155 | BTG2 | NA | BTG2 Entrez,  Source | BTG family, member 2 | 17959 | -2.061 | -0.0499 | No |
| 156 | DCN | NA | DCN Entrez,  Source | decorin | 18141 | -3.763 | -0.0305 | No |
| 157 | BMF | NA | BMF Entrez,  Source | Bcl2 modifying factor | 18151 | -4.080 | 0.0009 | No |

